Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial

BACKGROUND: The World Health Organization (WHO) recently recommended the addition of a single low-dose of the gametocytocidal drug primaquine (PQ) to artemisinin-based combination therapy (ACT) in low transmission settings as a component of pre-elimination or elimination programmes. However, it is u...

Descripción completa

Detalles Bibliográficos
Autores principales: Mwaiswelo, Richard, Ngasala, Billy, Jovel, Irina, Aydin-Schmidt, Berit, Gosling, Roland, Premji, Zul, Mmbando, Bruno, Björkman, Anders, Mårtensson, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002101/
https://www.ncbi.nlm.nih.gov/pubmed/27565897
http://dx.doi.org/10.1186/s12936-016-1430-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002101/
https://www.ncbi.nlm.nih.gov/pubmed/27565897
http://dx.doi.org/10.1186/s12936-016-1430-3

Ejemplares similares